1. Home
  2. PNNT vs ACOG Comparison

PNNT vs ACOG Comparison

Compare PNNT & ACOG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo PennantPark Investment Corporation

PNNT

PennantPark Investment Corporation

N/A

Current Price

$3.33

Market Cap

227.2M

Sector

Finance

ML Signal

N/A

Logo Alpha Cognition Inc.

ACOG

Alpha Cognition Inc.

N/A

Current Price

$8.90

Market Cap

193.6M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
PNNT
ACOG
Founded
2007
2000
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
227.2M
193.6M
IPO Year
2007
2024

Fundamental Metrics

Financial Performance
Metric
PNNT
ACOG
Price
$3.33
$8.90
Analyst Decision
Hold
Strong Buy
Analyst Count
8
5
Target Price
$4.75
★ $18.00
AVG Volume (30 Days)
★ 424.4K
89.3K
Earning Date
08-10-2026
11-12-2026
Dividend Yield
★ 14.54%
N/A
EPS Growth
N/A
★ 41.58
EPS
★ N/A
N/A
Revenue
N/A
★ $10,220,275.00
Revenue This Year
N/A
$152.34
Revenue Next Year
$0.19
$91.54
P/E Ratio
$13.14
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.19
$4.50
52 Week High
$6.67
$10.14

Technical Indicators

Market Signals
Indicator
PNNT
ACOG
Relative Strength Index (RSI) 34.55 56.15
Support Level $3.19 $5.49
Resistance Level $3.89 $9.95
Average True Range (ATR) 0.09 0.47
MACD -0.02 0.01
Stochastic Oscillator 12.41 93.62

Price Performance

Historical Comparison
PNNT
ACOG

About PNNT PennantPark Investment Corporation

Pennant Park Investment Corp is a closed-end, non-diversified investment company. Its investment objective is to generate current income and capital appreciation also seeking to preserve capital through debt and equity investments. The company focuses on investing in United States middle-market companies that offer attractive risk-reward to investors and to create a diversified portfolio that includes senior secured debt, mezzanine debt, and equity investments. It generates majority of its revenue from interest and dividends received from investments made.

About ACOG Alpha Cognition Inc.

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimers disease, for which there are limited or no treatment options. The Companies current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Companies commercial development program for ZUNVEYL is focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

Share on Social Networks: